After a Q1 Blowout and a Soaring Share Price, Is AMD Stock Still a Buy?

AMD reported Q1 revenue of $10.3 billion, up 38% year over year and above the roughly $9.8 billion midpoint forecast, while data center revenue jumped 57% to $5.8 billion. Management guided Q2 revenue to about $11.2 billion, implying roughly 46% growth, and free cash flow more than tripled to a record $2.6 billion. Offset by a rich valuation near 150x earnings and expected near-term margin pressure from the MI450 ramp, the article argues AMD remains attractive only for investors comfortable with elevated AI execution risk.

Analysis

The market is no longer pricing AMD as a cyclical semis recovery story; it is pricing an AI platform shift with optionality on multiple ramps at once. The important second-order effect is that this kind of revenue mix change forces a re-rating of supplier expectations across the stack: advanced packaging, HBM memory, substrates, and foundry capacity all become more strategically scarce as AMD tries to convert design wins into volume. That should keep the ecosystem tight even if AMD itself stalls, but it also means AMD’s execution risk is now more about manufacturing cadence than demand discovery.

The real trap in the debate is not whether AI spend remains strong over the next quarter or two, but whether incremental customers force AMD into a lower-margin, earlier-stage product mix before the software stack matures. If MI450 ramps slower than expected, the market will punish the stock disproportionately because the multiple is already discounting a clean glide path to tens of billions in data-center AI revenue by 2027. Conversely, any evidence that lead customers are accelerating deployments would justify a further squeeze higher because the stock’s valuation embeds very little room for timing slippage.

Relative value still looks asymmetric against Nvidia only if one believes AMD can close the product/enablement gap without needing a permanent margin concession. That is a high bar: AMD’s upside is more levered to share gain, but the downside is more exposed to supply-chain hiccups, customer concentration, and sentiment reversals in AI capex. In other words, the stock is attractive as a momentum expression, not as a margin-of-safety long.

The consensus is likely underestimating how much of AMD’s current bid is driven by scarcity of credible second-sourcing in AI accelerators. That supports the shares in the medium term, but it also means any broad AI rotation out of high-beta semis could hit AMD harder than the larger incumbent because its forward multiple has already pulled a lot of 2027 into today’s price.

Key Decisions for Investors

• Avoid adding fresh outright long AMD at current levels; if already long, treat it as a trading position and trim 25-33% on strength over the next 1-3 weeks to reduce multiple risk.
• For investors wanting AI semis exposure, prefer a pair trade: long NVDA / short AMD for the next 3-6 months if you expect execution dispersion to matter more than valuation gap closing; AMD needs flawless MI450 ramp to justify the premium.
• If initiating AMD exposure, use call spreads rather than stock: buy 3-6 month upside calls financed with higher strikes to express continued AI enthusiasm while capping downside from any guidance reset.
• Watch for a better entry on any post-earnings or supply-chain-related drawdown of 10-15%; that would likely be the first point where risk/reward improves materially for a medium-term long.
• Secondary beneficiary basket: prefer a modest long in META on weakness versus AMD for a lower-risk way to play AI capex durability, since META’s spend can validate demand while avoiding AMD’s execution premium.